Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

CD133 Expression and Cancer Stem Cells Predict Prognosis in High‐grade Oligodendroglial Tumors

27 Mar 2008

Abstract excerpt

High-grade oligodendroglial tumors, that is, anaplastic oligodendroglial tumors and glioblastomas with oligodendroglial component, differ significantly in terms of prognosis and response to chemotherapy. Differentiation might be difficult because the histological differences are vague and reliable markers are not established. We correlated the presence of putative cancer stem cells (CSC) in high-grade...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Cancer Cells and Metastasis
Share to Cancer-related molecular mechanisms research
Share to Glioma Diagnosis and Treatment

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Source

Identifiers

PMID: 18371181
DOI: 10.1111/j.1750-3639.2008.00130.x

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 8 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

CD133 Expression and Cancer Stem Cells Predict Prognosis in High‐grade Oligodendroglial TumorsPMID 18371181Read ↗

Glial progenitor-like phenotype in low-grade glioma and enhanced CD133-expression and neuronal lineage differentiation potential in high-grade glioma.Semantic proximity Read ↗

Glioblastoma-derived stem cell-enriched cultures form distinct subgroups according to molecular and phenotypic criteria.Semantic proximity Read ↗

Current Strategies for Identification of Glioma Stem Cells: Adequate or Unsatisfactory?Semantic proximity Read ↗

CD133+ and CD133− Glioblastoma-Derived Cancer Stem Cells Show Differential Growth Characteristics and Molecular ProfilesSemantic proximity Read ↗

CD133 Is Essential for Glioblastoma Stem Cell MaintenanceSemantic proximity Read ↗

Immunophenotypic characterization of human glioblastoma stem cells: correlation with clinical outcome.Semantic proximity Read ↗

Content of stem tumor CD133+ cells in brain neoplasms of different histological type.Semantic proximity Read ↗

A distinct subpopulation within CD133 positive brain tumor cells shares characteristics with endothelial progenitor cells.Semantic proximity Read ↗

Targeting Glioblastoma Stem Cells: Cell Surface MarkersSemantic proximity Read ↗

Heterogeneous phenotype of human glioblastoma: in vitro study.Semantic proximity Read ↗

Identification of cancer stem cells from human glioblastomas: growth and differentiation capabilities and CD133/prominin‐1 expressionSemantic proximity Read ↗

Clinical and biological implications of CD133-positive and CD133-negative cells in glioblastomasSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.